Welcome to Medications.com
Arpida Reports Progress in Pivotal Phase III Trial With TLT ... - Trading Markets (press release)
The TLT therapy consists of a one-time laser pre-treatment, followed by daily application of a topical terbinafine (the active substance of Lamisil(R)) ...
http://www.tradingmarkets.com/.si... |
Posted: Tue Jan 22 03:18:07 -0500 2008
Lamisil Topical RSS FeedFrequently Reported Side Effects of Lamisil Topical
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
